Related Experiment Video
Updated: Mar 31, 2026

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
The medicinal chemist's toolbox for late stage functionalization of drug-like molecules
Tim Cernak1, Kevin D Dykstra, Sriram Tyagarajan
1Merck Research Laboratories, Discovery Chemistry - Automation & Capabilities Enhancement, 33 Avenue Louis Pasteur, BMB2-116B, Boston, Massachusetts 02115, USA. timothy_cernak@merck.com.
Abstract:
The advent of modern C-H functionalization chemistries has enabled medicinal chemists to consider a synthetic strategy, late stage functionalization (LSF), which utilizes the C-H bonds of drug leads as points of diversification for generating new analogs. LSF approaches offer the promise of rapid exploration of structure activity relationships (SAR), the generation of oxidized metabolites, the blocking of metabolic hot spots and the preparation of biological probes. This review details a toolbox of intermolecular C-H functionalization chemistries with proven applicability to drug-like molecules, classified by regioselectivity patterns, and gives guidance on how to systematically develop LSF strategies using these patterns and other considerations. In addition, a number of examples illustrate how LSF approaches have been used to impact actual drug discovery and chemical biology efforts.
Related Concept Videos
Drug Discovery: Overview
Drug Biotransformation: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Metabolism: Phase II Reactions
Phase I Oxidative Reactions: Overview

